How much dividend does IDEXX Laboratories pay?
Over the past 12 months, IDEXX Laboratories paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, IDEXX Laboratories is expected to pay a dividend of 0 USD.
According to the latest status from August 2024, IDEXX Laboratories paid a total of 0 USD per share in dividends within the last 12 months. With the current IDEXX Laboratories price of 492.26 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.
= |
A dividend is paid times per year. Last year, the payout months were and .
Paydate | Dividend |
---|
IDEXX Laboratories has been increasing the dividend for 0 years.
Over the past 10 years, IDEXX Laboratories has increased it by an annual 0 %.
Over a five-year period, the distribution increased by 0%.
Analysts expect a Dividend Cut of -100% for the current fiscal year.
In the annual report of the IDEXX Laboratories share (US45168D1046, 888210, IDXX), it breaks down its revenues into 4 segments: 1. Companion Animal Group, 2. Water, 3. Livestock, Poultry & Dairy, 4. Other. The IDEXX Laboratories stock (WKN: 888210, ISIN: US45168D1046, Ticker Symbol: IDXX) is a leading investment for investors interested in participating in the Health Care sector.
IDEXX Laboratories’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Examining IDEXX Laboratories's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
IDEXX Laboratories's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Changes in IDEXX Laboratories’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
The IDEXX Laboratories stock can be added to a savings plan with the following providers: Trade Republic and Consorsbank
Over the past 12 months, IDEXX Laboratories paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, IDEXX Laboratories is expected to pay a dividend of 0 USD.
The current dividend yield of IDEXX Laboratories is .
IDEXX Laboratories pays a quarterly dividend. This is distributed in the months of .
IDEXX Laboratories paid dividends every year for the past 0 years.
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
IDEXX Laboratories is assigned to the 'Health' sector.
To receive the latest dividend of IDEXX Laboratories from 8/17/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/17/2024.
The last dividend was paid out on 8/17/2024.
In the year 2023, IDEXX Laboratories distributed 0 USD as dividends.
The dividends of IDEXX Laboratories are distributed in USD.
Our stock analysis for IDEXX Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of IDEXX Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.